These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9579543)

  • 21. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma.
    Vowels BR; Lessin SR; Cassin M; Jaworsky C; Benoit B; Wolfe JT; Rook AH
    J Invest Dermatol; 1994 Nov; 103(5):669-73. PubMed ID: 7963654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
    Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM
    Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma.
    Cesarman E; Inghirami G; Chadburn A; Knowles DM
    Am J Pathol; 1993 Sep; 143(3):845-56. PubMed ID: 8103295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma.
    Rübben A; Kempf W; Kadin ME; Zimmermann DR; Burg G
    Exp Dermatol; 2004 Aug; 13(8):472-83. PubMed ID: 15265011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of SHP-1 tyrosine phosphatase expression correlates with the advanced stages of cutaneous T-cell lymphoma.
    Witkiewicz A; Raghunath P; Wasik A; Junkins-Hopkins JM; Jones D; Zhang Q; Odum N; Wasik MA
    Hum Pathol; 2007 Mar; 38(3):462-7. PubMed ID: 17239936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
    Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
    Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric DNA ploidy analysis of peripheral blood from patients with sezary syndrome: detection of aneuploid neoplastic T cells in the blood is associated with large cell transformation in tissue.
    Wang S; Li N; Heald P; Fisk JM; Fadare O; Howe JG; McNiff JM; Smith BR
    Am J Clin Pathol; 2004 Nov; 122(5):774-82. PubMed ID: 15491974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of p53 mutations with metastatic prostate cancer.
    Eastham JA; Stapleton AM; Gousse AE; Timme TL; Yang G; Slawin KM; Wheeler TM; Scardino PT; Thompson TC
    Clin Cancer Res; 1995 Oct; 1(10):1111-8. PubMed ID: 9815901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
    Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
    J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 alterations in chemically induced hamster cheek-pouch lesions.
    Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
    Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study.
    Salhany KE; Cousar JB; Greer JP; Casey TT; Fields JP; Collins RD
    Am J Pathol; 1988 Aug; 132(2):265-77. PubMed ID: 3261136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 immunoreactivity is uncommon in primary cutaneous lymphoma.
    McGregor JM; Dublin EA; Levison DA; MacDonald DM; Smith NP; Whittaker S
    Br J Dermatol; 1995 Mar; 132(3):353-8. PubMed ID: 7718450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 and bcl-2 expression do not correlate with prognosis in primary cutaneous large T-cell lymphomas.
    van Haselen CW; Vermeer MH; Toonstra J; van der Putte SC; Mulder PG; van Vloten WA; Willemze R
    J Cutan Pathol; 1997 Sep; 24(8):462-7. PubMed ID: 9331891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognizing large-cell transformation of mycosis fungoides.
    Herrmann JL; Hughey LC
    J Am Acad Dermatol; 2012 Oct; 67(4):665-72. PubMed ID: 22261416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
    O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL
    Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.